glp-1 weight loss insurance Perspectives from employers on the costs and issues associated with covering agonists for Employers Grapple with Claims Costs

Many patients wonder whether medications like semaglutide directly lower cortisol levels or simply improve metabolic health in ways that reduce the body's need for excess cortisol production

Anatomy of Facial Volume Loss in Weight Reduction Understanding the nuances of facial anatomy is a critical first step in addressing volume loss in patients using GLP-1 agonists, said Sanja Cypen, MD, an oculofacial plastic surgeon at the Center for Excellence in Eye Care in Miami

Exercise & Stress Management Regular movement maintains kidney function

The interface between the human microbiome and disease states presents numerous opportunities for advancement

Cardiovasc Diabetol 21 , 169 (2022)